LifeStance Health Group, Inc. (NASDAQ: LFST) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $10.00 price target on the stock.
Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group [Yahoo! Finance]
Zarminali Health Launches with $40M in Seed Funding to Transform Pediatric Care through Nationwide, Multi-specialty Practice Group
LifeStance Health Group, Inc. (NASDAQ: LFST) had its price target raised by analysts at Barclays PLC from $6.00 to $7.00. They now have an "underweight" rating on the stock.
LifeStance Health Group Inc (LFST) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]